↓ Skip to main content

Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis

Overview of attention for article published in Frontiers in oncology, February 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis
Published in
Frontiers in oncology, February 2021
DOI 10.3389/fonc.2020.624573
Pubmed ID
Authors

Gregory P. Kaufman, Claudio Cerchione

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 3 16%
Student > Bachelor 3 16%
Professor 1 5%
Researcher 1 5%
Student > Postgraduate 1 5%
Other 0 0%
Unknown 10 53%
Readers by discipline Count As %
Medicine and Dentistry 3 16%
Biochemistry, Genetics and Molecular Biology 2 11%
Psychology 1 5%
Business, Management and Accounting 1 5%
Physics and Astronomy 1 5%
Other 1 5%
Unknown 10 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 December 2021.
All research outputs
#8,192,846
of 25,387,668 outputs
Outputs from Frontiers in oncology
#3,026
of 22,433 outputs
Outputs of similar age
#196,870
of 528,009 outputs
Outputs of similar age from Frontiers in oncology
#146
of 841 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 22,433 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 528,009 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 841 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.